Introduction: Post-traumatic stress disorder (PTSD) has been associated with immune disturbances, including a higher incidence of infections and autoimmune diseases as well as a net pro-inflammatory state. Natural killer (NK) cells, a key component of the innate immune system, have been less wellstudied in PTSD despite their importance in immunity. Methods: We studied two independent samples of combat-exposed male war veterans with or without PTSD, the first (''Discovery Sample") to generate hypotheses, and the second (''Validation Sample") to replicate the findings. The Discovery Sample was comprised of 42 PTSD subjects and 42 controls. The Validation Sample was comprised of 25 PTSD subjects and 30 controls. Participants had fasting, morning blood samples collected for examination of the frequency of NK cell subsets, determined by flow cytometry. The current and lifetime Clinician Administered PTSD Scale (CAPS) was used to assess symptom severity. Statistical analyses were adjusted for age and BMI. Results: PTSD subjects compared to controls had (i) a significantly higher relative frequency of atypical CD56 
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